There are a number of biologics approved to treat rheumatoid arthritis. These include:
- Abatacept (Orencia)
- Adalimumab (Humira)
- Adalimumab-adbm (Cyltezo), a biosimilar to Humira
- Adalimumab-atto (Amjevita), a biosimilar to Humira
- Anakinra(Kineret)
- Certolizumab pegol (Cimzia)
- Etanercept (Enbrel)
- Etanercept-szzs (Erelzi), a biosimilar to Enbrel
- Golimumab (Simponi, Simponi Aria)
- Infliximab(Remicade)
- Infliximab-dyyb (Inflectra), a biosimilar to Remicade
- Rituximab (Rituxan)
- Tocilizumab (Actemra)